CLIN CHEM:直接比较2条排除急性心肌梗死诊断规则策略

2017-07-25 MedSci MedSci原创

近日,国际杂志 《Clinical Chemistry》上在线发表一项关于直接比较2条排除急性心肌梗死诊断规则策略,即2小时加速诊断方案与2小时算法比较。

近日,国际杂志 《Clinical Chemistry》上在线发表一项关于直接比较2条排除急性心肌梗死诊断规则策略,即2小时加速诊断方案与2小时算法比较。

研究人员将患者基于2小时诊断方案的2项高敏心肌肌钙蛋白(hs-cTn)与急诊(ED)疑似急性心肌梗死AMI)进行比较:结合hs-cTn2 h加速诊断方案(2h-ADP),心电图和风险评分,以及仅基于hs-cTn浓度及其绝对变化的2-h算法。

分析在2个独立的诊断队列中进行,并采用hs-cTnTElecsys)和hs-cTnI[欧洲高级急性冠状动脉综合征评估预测(APACE)研究,澳大利亚-新西兰2-h加速诊断方案来使用肌钙蛋白作为唯一的生物标志物(ADAPT )评估患有胸痛症状的患者]。最终诊断由2名独立的心脏病专家评估。

APACE1372例患者的16.5%诊断为AMI95CI14.6-18.6%),ADAPT1153例的12.6%(95CI10.7-14.7%)为AMIAMI的阴性预测值(NPV)和敏感性非常高,并且与两组中使用hs-cTnThs-cTnI的两种策略(所有统计比较无显著性)相当。2h-ADP36-43%)排除筛选的病人比例明显低于2-h算法(55-68%)(P <0.001)。30天主要不良心血管事件的2h-ADP敏感性较高。

通过AMINPV和敏感性以及主要不良心脏事件(MACE)定量的两种算法在30天内患者筛选排除能够提供非常高的和可比较的安全性。尽管在30天内在队列2的两种算法MACE敏感性较低。虽然2-h算法更有效,但并不是所有患者排除AMI的算法均可作为早期出院的标志。从ED中选择早期出院的患者,2h-ADP似乎更好。

原始出处:

Karin Wildi, Louise Cullen, Raphael Twerenboldet al. Direct Comparison of 2 Rule-Out Strategies for Acute Myocardial Infarction: 2-h Accelerated Diagnostic Protocol vs 2-h Algorithm

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=226632, encodeId=15e9226632b3, content=谢谢分享,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Wed Jul 26 19:51:27 CST 2017, time=2017-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226274, encodeId=d4d92262e493, content=学习了分享了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/21/39b6a0099eb602e8ac1f7e10d5d440a9.jpg, createdBy=dee01724555, createdName=杨利洪, createdTime=Tue Jul 25 21:21:11 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226271, encodeId=998b2262e135, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Jul 25 21:03:05 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226259, encodeId=e999226259cf, content=学习了,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jul 25 19:40:25 CST 2017, time=2017-07-25, status=1, ipAttribution=)]
    2017-07-26 laoli

    谢谢分享,学习了!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=226632, encodeId=15e9226632b3, content=谢谢分享,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Wed Jul 26 19:51:27 CST 2017, time=2017-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226274, encodeId=d4d92262e493, content=学习了分享了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/21/39b6a0099eb602e8ac1f7e10d5d440a9.jpg, createdBy=dee01724555, createdName=杨利洪, createdTime=Tue Jul 25 21:21:11 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226271, encodeId=998b2262e135, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Jul 25 21:03:05 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226259, encodeId=e999226259cf, content=学习了,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jul 25 19:40:25 CST 2017, time=2017-07-25, status=1, ipAttribution=)]
    2017-07-25 杨利洪

    学习了分享了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=226632, encodeId=15e9226632b3, content=谢谢分享,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Wed Jul 26 19:51:27 CST 2017, time=2017-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226274, encodeId=d4d92262e493, content=学习了分享了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/21/39b6a0099eb602e8ac1f7e10d5d440a9.jpg, createdBy=dee01724555, createdName=杨利洪, createdTime=Tue Jul 25 21:21:11 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226271, encodeId=998b2262e135, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Jul 25 21:03:05 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226259, encodeId=e999226259cf, content=学习了,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jul 25 19:40:25 CST 2017, time=2017-07-25, status=1, ipAttribution=)]
    2017-07-25 明月清辉

    谢谢分享,学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=226632, encodeId=15e9226632b3, content=谢谢分享,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Wed Jul 26 19:51:27 CST 2017, time=2017-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226274, encodeId=d4d92262e493, content=学习了分享了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/21/39b6a0099eb602e8ac1f7e10d5d440a9.jpg, createdBy=dee01724555, createdName=杨利洪, createdTime=Tue Jul 25 21:21:11 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226271, encodeId=998b2262e135, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Jul 25 21:03:05 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=226259, encodeId=e999226259cf, content=学习了,涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Jul 25 19:40:25 CST 2017, time=2017-07-25, status=1, ipAttribution=)]
    2017-07-25 1ddf0692m34(暂无匿称)

    学习了,涨知识

    0

相关资讯

JAMA Intern Med:冠状动脉无创造影与非缺血性胸痛

研究表明非缺血性胸痛患者进行心脏测试会增加患者下游二次检测率,且该类患者的急性心肌梗死风险较低。该研究结果认为对于符合非缺血性胸痛的患者冠状动脉无创造影是不必要的。

CLIN CHEM:血清制备过程产生的小分子会影响心肌梗死的诊断?

心肌肌钙蛋白T(cTnT)是目前已知急性心肌梗死(AMI)的公认生物标志,但是它在血清中易于被蛋白水解降解。这种降解通常归因于μ钙蛋白酶的作用,尽管也可能有其它原因。近日,临床化学杂志(Clinical Chemistry)在线发表了一项采用免疫印迹和质谱(MS)分析方法研究 cTnT降解的研究。在本研究中,研究人员探讨了血清样品制备的过程中凝血酶介导的cTnT切割发生的假说。

Drug Saf:急性心梗/IS患者:强效缓释阿片类药物会引发缺血性心脑血管事件?

2017年6月,发表在《Drug Saf》的一项由德国科学家进行的巢式病例对照研究,考察了与羟考酮-纳洛酮及其他强效缓释阿片类药物相关的缺血性心脑血管事件的风险。

J Clin Periodontol:心肌梗死患者唾液及血清相关生物标志物水平

目的:研究唾液中的半胱氨酸蛋白酶抑制剂C和生长分化因子-15(GDF-15)的心肌标志物与心肌梗死(MI)和牙周状态的关系,并研究唾液和血清心肌标志物之间的关系。

Nursing studies:吸氧治疗并不会改善血氧饱和度正常的急性心肌梗死患者的治疗效果

急性心肌梗死患者吸氧的益处或风险目前并不清楚。本研究旨在通过系统荟萃和荟萃分析探究急性心肌梗死患者吸氧治疗的有效性和安全性。研究人员检索了2016年6月以前收录在PubMed,EMBASE,Web of Science以及Cochrane Library的相关随机控制试验。所纳入的随机控制试验评估了急性心肌梗死患者吸氧治疗的有效性和安全性。主要结果是短期心肌梗死的死亡率和复发率,次要结果是心律失常

JAHA:急性心肌梗死住院早期和晚期心源性休克发病率和短期预后的趋势!

由此可见,院前和住院发发生的CS与较差的短期生存和住院死亡率相关,并且在那些院前CS患者中随着时间推移有所增加。主要集中在预防或治疗院前和晚期CS的干预措施是很有必要的,以改善急性心肌梗死后住院生存。